![Nicholas J Schork](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nicholas J Schork
Amministratore Delegato presso Myi Diagnostics & Discovery, Inc.
Profilo
Nicholas J Schork is associated with Myi Diagnostics & Discovery, Inc. as the Chief Executive Officer since 2015.
Dr. Schork is also the founder of Seraphina Therapeutics, Inc.
Posizioni attive di Nicholas J Schork
Società | Posizione | Inizio |
---|---|---|
Myi Diagnostics & Discovery, Inc.
![]() Myi Diagnostics & Discovery, Inc. BiotechnologyHealth Technology MYi Diagnostics & Discovery, Inc. provides diagnostic assays for longitudinal profiling of blood and other tissues applicable to the monitoring of healthy, disease-predisposed, and treated individuals. The firm also develops multiplexed immunocytochemical analytical platforms for assaying patient biopsies to identify the unique biomarkers that identify diseased cells. The company was founded by Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor on September 8, 2015 and is headquartered in San Diego, CA. | Amministratore Delegato | 08/09/2015 |
Seraphina Therapeutics, Inc.
![]() Seraphina Therapeutics, Inc. Medical/Nursing ServicesHealth Services Seraphina Therapeutics, Inc. operates as a health and wellness company. The company was founded by Stephanie Venn-Watson, Eric Venn-Watson, Nicholas J. Schork and Kim Kamdar and is headquartered in San Diego ,CA. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Myi Diagnostics & Discovery, Inc.
![]() Myi Diagnostics & Discovery, Inc. BiotechnologyHealth Technology MYi Diagnostics & Discovery, Inc. provides diagnostic assays for longitudinal profiling of blood and other tissues applicable to the monitoring of healthy, disease-predisposed, and treated individuals. The firm also develops multiplexed immunocytochemical analytical platforms for assaying patient biopsies to identify the unique biomarkers that identify diseased cells. The company was founded by Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor on September 8, 2015 and is headquartered in San Diego, CA. | Health Technology |
Seraphina Therapeutics, Inc.
![]() Seraphina Therapeutics, Inc. Medical/Nursing ServicesHealth Services Seraphina Therapeutics, Inc. operates as a health and wellness company. The company was founded by Stephanie Venn-Watson, Eric Venn-Watson, Nicholas J. Schork and Kim Kamdar and is headquartered in San Diego ,CA. | Health Services |
- Borsa valori
- Insiders
- Nicholas J Schork